TY - JOUR
T1 - Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications
AU - Lim, Chooi Ling
AU - Raju, Chandramathi S.
AU - Mahboob, Tooba
AU - Kayesth, Sunil
AU - Gupta, Kamal K.
AU - Jain, Gaurav Kumar
AU - Dhobi, Mahaveer
AU - Nawaz, Muhammad
AU - Wilairatana, Polrat
AU - Pereira, Maria de Lourdes
AU - Patra, Jayanta Kumar
AU - Paul, Alok K.
AU - Rahmatullah, Mohammed
AU - Nissapatorn, Veeranoot
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Phytopharmaceuticals have been widely used globally since ancient times and acknowledged by healthcare professionals and patients for their superior therapeutic value and fewer side-effects compared to modern medicines. However, phytopharmaceuticals need a scientific and methodical approach to deliver their components and thereby improve patient compliance and treatment adherence. Dose reduction, improved bioavailability, receptor selective binding, and targeted delivery of phytopharmaceuticals can be likely achieved by molding them into specific nano-formulations. In recent decades, nanotechnology-based phytopharmaceuticals have emerged as potential therapeutic candidates for the treatment of various communicable and non-communicable diseases. Nanotechnology combined with phytopharmaceuticals broadens the therapeutic perspective and overcomes problems associated with plant medicine. The current review highlights the therapeutic application of various nano-phytopharmaceuticals in neurological, cardiovascular, pulmonary, and gastro-intestinal disorders. We conclude that nano-phytopharmaceuticals emerge as promising therapeutics for many pathological conditions with good compliance and higher acceptance.
AB - Phytopharmaceuticals have been widely used globally since ancient times and acknowledged by healthcare professionals and patients for their superior therapeutic value and fewer side-effects compared to modern medicines. However, phytopharmaceuticals need a scientific and methodical approach to deliver their components and thereby improve patient compliance and treatment adherence. Dose reduction, improved bioavailability, receptor selective binding, and targeted delivery of phytopharmaceuticals can be likely achieved by molding them into specific nano-formulations. In recent decades, nanotechnology-based phytopharmaceuticals have emerged as potential therapeutic candidates for the treatment of various communicable and non-communicable diseases. Nanotechnology combined with phytopharmaceuticals broadens the therapeutic perspective and overcomes problems associated with plant medicine. The current review highlights the therapeutic application of various nano-phytopharmaceuticals in neurological, cardiovascular, pulmonary, and gastro-intestinal disorders. We conclude that nano-phytopharmaceuticals emerge as promising therapeutics for many pathological conditions with good compliance and higher acceptance.
KW - Herbal medications
KW - Nano-formulations
KW - Phytopharmaceuticals
KW - Precision
KW - Therapeutics
UR - http://www.scopus.com/inward/record.url?scp=85122690898&partnerID=8YFLogxK
U2 - 10.3390/nano12020238
DO - 10.3390/nano12020238
M3 - Review article
AN - SCOPUS:85122690898
SN - 2079-4991
VL - 12
JO - Nanomaterials
JF - Nanomaterials
IS - 2
M1 - 238
ER -